XML 89 R78.htm IDEA: XBRL DOCUMENT v3.24.2.u1
POLICY LIABILITIES - Reconciliation of Future Policy Benefits (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits $ 70,339 $ 83,718
Deferred reinsurance gain liability 148 175
Deferred Profit Liability - Limited-payment Contracts    
Liability for Future Policy Benefit, Activity [Line Items]    
Deferred profit liability - limited-payment contracts 1,667 1,806
Deferred reinsurance gain liability 820 1,012
Intercompany eliminations    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits [1] (4,089) (5,017)
Corporate and other | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 3,405 4,225
Cancer | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 26,896 32,652
Cancer | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 26,896 32,652
Medical and other health | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 8,576 10,560
Medical and other health | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 8,576 10,560
Life insurance | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 19,092 23,243
Life insurance | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 19,092 23,243
Life insurance | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 894 911
Life insurance | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 894 911
Accident | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 597 621
Accident | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 597 621
Disability | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 744 770
Disability | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 744 770
Critical Care | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 6,842 7,216
Critical Care | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 6,842 7,216
Hospital Indemnity | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 789 836
Hospital Indemnity | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 789 836
Dental/Vision | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 260 272
Dental/Vision | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 260 272
Other | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 3,353 4,090
Other | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 3,353 4,090
Other | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 493 521
Other | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits $ 493 $ 521
[1] Elimination entry necessary due to the internal reinsurance transactions with Aflac Re and to recapture a portion of policy liabilities ceded externally as a result of the reinsurance retrocession transaction. See Note 8 of the Notes to the Consolidated Financial Statements in the 2023 Annual Report.